Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer
{{output}}
Objective: Treatment options for metastatic castration resistant prostate cancer (mCRPC) have expanded rapidly in recent years. Given the significant economic burden, we sought perform a cost-effectiveness analysis (CEA) of the c... ...
